Abstract
Most somatic human cells lack telomerase activity because they do not express the telomerase reverse transcriptase (hTERT) gene. Conversely, most cancer cells express hTERT and are telomerase positive. For most tumors it is not clear whether hTERT expression is due to their origin from telomerase positive stem cells or to reactivation of the gene during tumorigenesis. Telomerase negative cells lack detectable cytoplasmic and nuclear hTERT transcripts; in telomerase positive cells 0.2 to 6 mRNA molecules/cell can be detected. This suggests that expression is regulated by changes in the rate of hTERT gene transcription. In tumor cell lines hTERT expression behaves like a recessive trait, indicating that lack of expression in normal cells is due to one or several repressors. Studies with monochromosomal hybrids indicate that several chromosomes may code for such repressors. A number of transcription factors, tumor suppressors, cell cycle inhibitors, cell fate determining molecules, hormone receptors and viral proteins have been implicated in the control of hTERT expression; but these studies have not yet provided a clear explanation for the tumor specific expression of the hTERT gene, and the cis-acting elements which are the targets of repression in normal cells still have to be identified.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aldous WK, Marean AJ, DeHart MJ, Matej LA, Moore KH . 1999 Cancer 85: 1523–1529
Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA . 2000 Nature 406: 641–645
Backsch C, Wagenbach N, Nonn M, Leistritz S, Stanbridge E, Schneider A, Durst M . 2001 Genes Chromo. Cancer 31: 196–198
Baur JA, Zou Y, Shay JW, Wright WE . 2001 Science 292: 2075–2077
Bednarek AK, Chu YL, Aldaz CM . 1998 Oncogene 16: 381–385
Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW . 1997 Cell 91: 25–34
Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu C-P, Morin GB, Harley CB, Shay JW, Lichtsteinter S, Wright WE . 1998 Science 279: 349–352
Braunstein I, Cohen-Barak O, Shachaf C, Ravel Y, Yalon-Hacohen M, Mills GB, Tzukerman M, Skorecki KL . 2001 Cancer Res. 61: 5529–5536
Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR . 1995 EMBO J. 14: 4240–4248
Bryce LA, Morrison N, Hoare SF, Muir S, Keith WN . 2000 Neoplasia 2: 197–201
Carroll T, Maltby E, Brock I, Royds J, Timperley W, Jellinek D . 1999 J. Pathol. 188: 395–399
Chiu CP, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, Harley CB, Lansdorp PM . 1996 Stem Cells 14: 239–248
Cong YS, Bacchetti S . 2000 J. Biol. Chem. 275: 35665–35668
Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M . 1997 Cell 89: 215–225
Coquelle A, Toledo F, Stern S, Bieth A, Debatisse M . 1998 Mol. Cell. 2: 259–265
Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S . 1992 EMBO J. 11: 1921–1929
Crowe DL, Nguyen DC, Tsang KJ, Kyo S . 2001 Nucleic Acids Res. 29: 2789–2794
Cuthbert AP, Bond J, Trott DA, Gill S, Broni J, Marriott A, Khoudoli G, Parkinson EK, Cooper CS, Newbold RF . 1999 J. Natl. Cancer Inst. 91: 37–45
Cuthbert AP, Trott DA, Ekong RM, Jezzard S, England NL, Themis M, Todd CM, Newbold RF . 1995 Cytogene. Cell Genetics 71: 68–76
Dessain SK, Yu H, Reddel RR, Beijersbergen RL, Weinberg RA . 2000 Cancer Res. 60: 537–541
Devereux TR, Horikawa I, Anna CH, Annab LA, Afshari CA, Barrett JC . 1999 Cancer Res. 59: 6087–6090
Ducrest AL, Amacker M, Mathieu YD, Cuthbert AP, Trott DA, Newbold RF, Nabholz M, Lingner J . 2001 Cancer Res. 61: 7594–7602
Duncan EL, Reddel RR . 1997 Biochemistry-Moscow 62: 1263–1274
Dunham MA, Neumann AA, Fasching CL, Reddel RR . 2000 Nat. Genet. 26: 447–450
Evans SK, Lundblad V . 2000 J. Cell Science 113: 3357–3364
Friebe B, Kynast RG, Zhang P, Qi L, Dhar M, Gill BS . 2001 Chromosome Res 9: 137–146
Fujimoto K, Kyo S, Takakura M, Kanaya T, Kitagawa Y, Itoh H, Takahashi M, Inoue M . 2000 Nucleic Acids Res. 28: 2557–2562
Gewin L, Galloway DA . 2001 J. Virol. 75: 7198–7201
Godhino Ferreira M, Promisel Cooper J . 2001 Mol. Cell. 7: 55–63
Grandori C, Cowley SM, James LP, Eisenman R.N . 2000 Annu. Rev. Cell. Dev. Biol. 16: 653–699
Greaves M . 1996 Trends Genet. 12: 127–128
Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB, DePinho RA . 1999 Oncogene 18: 1219–1226
Gunes C, Lichtsteiner S, Vasserot AP, Englert C . 2000 Cancer Res. 60: 2116–2121
Hackett JA, Feldser DM, Greider CW . 2001 Cell 106: 275–286
Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A, Beijersbergen RL, Knoll JH, Meyerson M, Weinberg RA . 1999 Nat. Med. 5: 1164–1170
Hande MP, Lansdorp PM, Natarajan AT . 1998 Mutat. Res. 404: 205–214
Harley CB, Futcher AB, Greider CW . 1990 Nature 345: 458–460
Hensler PJ, Annab LA, Barrett JC, Pereira-Smith OM . 1994 Mol. Cell. Biol. 14: 2291–2297
Hilakivi-Clarke L . 2000 Cancer Res. 60: 4993–5001
Horikawa I, Barrett JC . 2001 J. Natl. Cancer Inst. 93: 1171–1173
Horikawa I, Cable PL, Afshari C, Barrett JC . 1999 Cancer Res. 59: 826–830
Horikawa I, Oshimura M, Barrett JC . 1998 Mol. Carcinog. 22: 65–72
Huffman KE, Levene SD, Tesmer VM, Shay JW, Wright WE . 2000 J. Biol. Chem. 275: 19719–19722
Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, Chiu CP . 1999 Nat. Genet. 21: 111–114
Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H, Inoue M . 2000 Clin. Cancer Res. 6: 1239–1247
Kang SS, Kwon T, Kwon DY, Do SI . 1999 J. Biol. Chem. 274: 13085–13090
Kharbanda S, Kumar V, Dhar S, Pandey P, Chen C, Majumder P, Yuan ZM, Whang Y, Strauss W, Pandita TK, Weaver D, Kufe D . 2000 Curr. Biol. 10: 568–575
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW . 1994 Science 266: 2011–2015
Kitagawa Y, Kyo S, Takakura M, Kanaya T, Koshida K, Namiki M, Inoue M . 2000 Clin. Cancer Res. 6: 2868–2875
Knight JS, Cotter MA, Robertson ES . 2001 J. Biol. Chem. 276: 22971–22978
Koi M, Shimizu M, Morita H, Yamada H, Oshimura M . 1989 Jpn. J. Cancer Res. 80: 413–418
Kok K, Naylor SL, Buys CH . 1997 Adv. Cancer Res. 71: 27–92
Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, Weinberg RA, Haber DA, Gerald WL . 1998 Nat. Genet. 19: 182–186
Kugoh H, Mitsuya K, Meguro M, Shigenami K, Schulz TC, Oshimura M . 1999 DNA Res. 6: 165–172
Kusumoto M, Ogawa T, Mizumoto K, Ueno H, Niiyama H, Sato N, Nakamura M, Tanaka M . 1999 Clin. Cancer Res. 5: 2140–2147
Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A, Inoue M . 1999 Cancer Res. 59: 5917–5921
Kyo S, Takakura M, Kohama T, Inoue M . 1997 Cancer Res. 57: 610–614
Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H, Inoue M . 2000 Nucleic Acids Res. 28: 669–677
Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, Depinho RA . 1998 Nature 392: 569–574
Liehr JG . 2000 Endocr. Rev. 21: 40–54
Liu K, Hodes RJ, Weng N . 2001 J. Immunol. 166: 4826–4830
Maitra A, Wistuba II, Washington C, Virmani AK, Ashfaq R, Milchgrub S, Gazdar AF, Minna JD . 2001 Am. J. Pathol. 159: 119–130
McClintock B . 1941 Genetics 26: 234–282
Meeker AK, Sommerfeld HJ, Coffey DS . 1996 Endocrinology 137: 5743–5746
Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Dickinson Caddle S, Ziaugra L, Beijershergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA . 1997 Cell 90: 785–795
Misiti S, Nanni S, Fontemaggi G, Cong YS, Wen J, Hirte HW, Piaggio G, Sacchi A, Pontecorvi A, Bacchetti S, Farsetti A . 2000 Mol. Cell. Biol. 20: 3764–3771
Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE, Shay JW . 1999 Nat. Genet. 21: 115–118
Nakabayashi K, Ogino H, Michishita E, Satoh N, Ayusawa D . 1999 Exp. Cell Res. 252: 376–382
Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR . 1997 Science 277: 955–959
Ning Y, Lovell M, Taylor L, Pereira-Smith OM . 1992 Cytogenet. Cell Genet. 60: 79–80
Nishimoto A, Miura N, Horikawa I, Kugoh H, Murakami Y, Hirohashi S, Kawasaki H, Gazdar AF, Shay JW, Barrett JC, Oshimura M . 2001 Oncogene 20: 828–835
Obaya AJ, Mateyak MK, Sedivy JM . 1999 Oncogene 18: 2934–2941
Oh S, Song Y, Yim J, Kim TK . 1999a J. Biol. Chem. 274: 37473–37478
Oh S, Song YH, Kim UJ, Yim J, Kim TK . 1999b Biochem. Biophys. Res. Commun. 263: 361–365
Oh S, Song YH, Yim J, Kim TK . 2000 Oncogene 19: 1485–1490
Oh ST, Kyo S, Laimins LA . 2001 J. Virol. 75: 5559–5566
Ohmura H, Tahara H, Suzuki M, Ide T, Shimizu M, Yoshida MA, Tahara E, Shay JW, Barrett JC, Oshimura M . 1995 Jpn. J. Cancer Res. 86: 899–904
Oshimura M, Barrett JC . 1997 Eur. J. Cancer 33: 710–715
Parshad R, Sanford KK . 2001 Crit. Rev. Oncol. Hematol. 37: 87–96
Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, Segal-Bendirdjian E . 2001 Proc. Natl. Acad. Sci. USA 98: 6662–6667
Reddel RR, Bryan TM, Murnane JP . 1997 Biochemistry 62: 1254–1262
Russo I, Silver AR, Cuthbert AP, Griffin DK, Trott DA, Newbold RF . 1998 Oncogene 17: 3417–3426
Saito T, Schneider A, Martel N, Mizumoto H, Bulgay-Moerschel M, Kudo R, Nakazawa H . 1997 Biochem. Biophys. Res. Commun. 231: 610–614
Sen S . 2000 Curr. Opin. Oncol. 12: 82–88
Shay JW, Wright WE . 1996 Trends Genet. 12: 129–131
Steenbergen RD, Kramer D, Meijer CJ, Walboomers JM, Trott DA, Cuthbert AP, Newbold RF, Overkamp WJ, Zdzienicka MZ, Snijders PJ . 2001 J. Natl. Cancer Inst. 93: 865–872
Szutorisz H, Palmqvist R, Roos G, Stenling R, Schorderet DF, Reddel R, Lingner J, Nabholz M . 2001 Oncogene 20: 2600–2605
Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M, Inoue M . 1999 Cancer Res. 59: 551–557
Takakura M, Kyo S, Sowa Y, Wang Z, Yatabe N, Maida Y, Tanaka M, Inoue M . 2001 Nucleic Acids Res. 29: 3006–3011
Tanaka H, Horikawa I, Kugoh H, Shimizu M, Barrett JC, Oshimura M . 1999 Mol. Carcinog. 25: 249–255
Tanaka H, Shimizu M, Horikawa I, Kugoh H, Yokota J, Barrett JC, Oshimura M . 1998 Genes Chrom. Cancer 23: 123–133
Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR . 2001 Int. J. Cancer 91: 644–649
van Steensel B, Smogorzewska A, de Lange T . 1998 Cell 92: 401–413
Varley H, Di S, Scherer SW, Royle NJ . 2000 Am. J. Hum. Genet. 67: 610–622
Vaziri H, Benchimol S . 1998 Curr. Biol. 8: 279–282
Vaziri H, Squire JA, Pandita TK, Bradley G, Kuba RM, Zhang H, Gulyas S, Hill RP, Nolan GP, Benchimol S . 1999 Mol. Cell. Biol. 19: 2373–2379
Veldman T, Horikawa I, Barrett JC, Schlegel R . 2001 J. Virol. 75: 4467–4472
Wang J, Xie LY, Allan S, Beach D, Hannon GJ . 1998 Genes Dev. 12: 1769–1774
Wang Z, Kyo S, Takakura M, Tanaka M, Yatabe N, Maida Y, Fujiwara M, Hayakawa J, Ohmichi M, Koike K, Inoue M . 2000 Cancer Res. 60: 5376–5381
Wick M, Zubov D, Hagen G . 1999 Gene 232: 97–106
Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW . 1996 Dev. Genet. 18: 173–179
Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R . 1999 Nat. Genet. 21: 220–224
Xu D, Popov N, Hou M, Wang Q, Bjorkholm M, Gruber A, Menkel AR, Henriksson M . 2001 Proc. Natl. Acad. Sci. USA 98: 3826–3831
Xu D, Wang Q, Gruber A, Bjorkholm M, Chen Z, Zaid A, Selivanova G, Peterson C, Wiman KG, Pisa P . 2000 Oncogene 19: 5123–5133
Yan P, Coindre JM, Benhattar J, Bosman FT, Guillou L . 1999 Cancer Res. 59: 3166–3170
Yan P, Saraga EP, Bouzourene H, Bosman FT, Benhattar J . 2001 J. Pathol. 193: 21–26
Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, Bodnar A, Bronstein A, Chiu CP, Herron GS . 1999a J. Biol. Chem. 274: 26141–26148
Yang X, Tahin Q, Hu YF, Russo IH, Balsara BR, Mihaila D, Slater C, Barrett JC, Russo J . 1999b Int. J. Oncol. 15: 629–638
Yu CC, Lo SC, Wang TC . 2001 Biochem. J. 355: 459–464
Zhang A, Zheng C, Lindvall C, Hou M, Ekedahl J, Lewensohn R, Yan Z, Yang X, Henriksson M, Blennow E, Nordenskjold M, Zetterberg A, Bjorkholm M, Gruber A, Xu D . 2000 Cancer Res. 60: 6230–6235
Acknowledgements
We thank Marc van de Wetering and Hans Clevers for providing us with RNA from colon carcinoma lines carrying tetracycline inducible dominant negative TCF variants, and allowing us to quote their unpublished results. One of us is much indebted to the medical and nursing staff of the Otorhinolaryngology unit of the Lausanne University Hospital and to Dr F Viani for their help in making it possible for him to get on with his contribution to the review. Work in the authors' laboratories is supported by the Swiss National Science Foundation, the Human Frontiers Science Program, the fifth framework program of the European Union (via the Bundesamt für Bildung und Wissenschaft, Bern), and Krebsforschung Schweiz and the Roche Research foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ducrest, AL., Szutorisz, H., Lingner, J. et al. Regulation of the human telomerase reverse transcriptase gene. Oncogene 21, 541–552 (2002). https://doi.org/10.1038/sj.onc.1205081
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205081
Keywords
This article is cited by
-
A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants
Scientific Reports (2021)
-
Evidence supporting the role of telomerase, MMP-9, and SIRT1 in attention-deficit/hyperactivity disorder (ADHD)
Journal of Neural Transmission (2020)
-
Epidemiological, clinical and genetic characterization of aplastic anemia patients in Pakistan
Annals of Hematology (2019)
-
Global analysis of tRNA and translation factor expression reveals a dynamic landscape of translational regulation in human cancers
Communications Biology (2018)
-
Interaction studies of carbon nanomaterials and plasma activated carbon nanomaterials solution with telomere binding protein
Scientific Reports (2017)